Medable
Medable, officially known as Medable Inc., is a pioneering force in the digital health industry, headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in decentralised clinical trials, transforming the way clinical research is conducted. With a focus on patient-centric solutions, Medable offers a comprehensive platform that streamlines trial processes, enhances patient engagement, and accelerates drug development. The company operates primarily in North America and Europe, providing innovative services that include remote patient monitoring, data collection, and trial management. Medable's unique approach leverages advanced technology to improve accessibility and efficiency in clinical trials, positioning it as a key player in the evolving landscape of healthcare. Notable achievements include partnerships with major pharmaceutical companies and recognition for its contributions to advancing clinical research methodologies.
DitchCarbon Score
How does Medable's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medable's score of 7 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medable's reported carbon emissions
Medable, headquartered in the United States, has set ambitious climate commitments aimed at significantly reducing its carbon footprint. Although specific emissions data for recent years is not available, the company has established clear targets for its greenhouse gas emissions. Medable is committed to maintaining zero emissions for both Scope 1 and Scope 2 by 2030, using 2021 as the base year. This commitment reflects an absolute reduction target of 100% for these scopes, which encompass direct emissions from owned or controlled sources and indirect emissions from the generation of purchased electricity, respectively. Additionally, Medable aims to measure and reduce its Scope 3 emissions, which include all other indirect emissions that occur in the value chain. These targets have been validated through the Science Based Targets initiative (SBTi), aligning with the necessary reductions to limit global warming to 1.5°C. As a small to medium-sized enterprise, Medable's proactive approach demonstrates its dedication to sustainability and climate responsibility within the software and services sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medable is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
